Hantz Financial Services, Inc. Kaleido Biosciences, Inc. Transaction History
Hantz Financial Services, Inc.
- $5.63 Billion
- Q3 2024
A detailed history of Hantz Financial Services, Inc. transactions in Kaleido Biosciences, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 350 shares of KLDO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350Holding current value
$0% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding KLDO
# of Institutions
2Shares Held
2.65KCall Options Held
0Put Options Held
0About Kaleido Biosciences, Inc.
- Ticker KLDO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,622,600
- Description
- Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...